Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News VALEANT PHARMACEUTICALS INTL INC T.VRX

Healthcare Drug Manufacturers - Specialty & Generic
"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSX:VRX)

Bausch Health Announces Exchange Offers and Consent Solicitations for Certain Existing Senior Notes with Support from Approximately 23% of Outstanding Existing Senior Notes

PR Newswire August 30, 2022

Bausch + Lomb Announces Statistically Significant Topline Results From The First Phase 3 Trial Of NOV03 (perfluorohexyloctane) In Dry Eye Disease Associated With Meibomian Gland Dysfunction

Canada NewsWire April 13, 2021

Bausch Health Companies Inc. Announces Fourth-Quarter And Full-Year 2020 Results And Provides 2021 Guidance

Canada NewsWire February 24, 2021

Bausch + Lomb Announces Scientific Data On Bausch + Lomb INFUSE(TM) Silicone Hydrogel Daily Disposable Contact Lenses To Be Presented At The Virtual Global Specialty Lens Symposium

Canada NewsWire January 20, 2021

Bausch + Lomb Introduces SimplifEYE(TM) IOL Delivery System For enVista® Toric And Monofocal Preloaded Intraocular Lenses

Canada NewsWire October 27, 2020

Salix To Present Data For Products Across Its Portfolio At The American College Of Gastroenterology 2020 Virtual Annual Meeting

Canada NewsWire October 22, 2020

Bausch Health Licenses Eyenovia's Investigational Treatment For The Reduction Of Pediatric Myopia Progression In Children Ages 3-12

Canada NewsWire October 12, 2020

Bausch Health Releases Annual Corporate Social Responsibility Report

Canada NewsWire September 23, 2020

Bausch Health To Participate At The 18th Annual Morgan Stanley Global Healthcare Conference

Canada NewsWire September 9, 2020
View More News ››

Opinion & Analysis (TSX:VRX)

What Andy Grove and Michael Milken have taught us about prostate cancer

The Life Sciences Report April 20, 2016

Drug pricing, presidential politics, and three biotechs with promise

The Life Sciences Report April 13, 2016

This ETF Has A Valeant Problem

Benzinga.com  September 30, 2015

Using ETFs To Run Your Own Hedge Fund

Benzinga.com  August 20, 2015

Lone Pine Capital Shuffles Its Top 5 Positions

Benzinga.com  May 18, 2015

Magna International (T.MG) shareholders bask in glow of rising share price

Stockhouse Editorial April 22, 2014
View More Opinion ››

Bullboard Posts (TSX:VRX)

Vpt diagnostics medical product

Be used across China now, that’s a market of billions. Each device goes for hefty amount with iver 1000 clinics purchased. Gonna be a...
Equalizer - March 6, 2019

IME, VXR,

Love me both big moves this year 
Equalizer - July 31, 2018

Bausch and Lomb may be pi$$ed at the name change to Bausch!

B&L website is Bausch.com.
lupitapat3 - July 13, 2018

RE:RE:Papa's got a brand new bag

You're welcome gentlemen. Nice Irish GREEN on a very RED day today for stocks. More to come. GL Dom
domcolumba - July 11, 2018

RE:Papa's got a brand new bag

Thank you very much for posting the link...Paul 
Sens1660 - July 11, 2018

RE:Papa's got a brand new bag

Good article, thanks for sharing it. I bought about 2 weeks ago and I am under the water. Hope the new name bring positive things
xhjszxhj - July 1, 2018
View more Bullboard ››

Nicola Mining Inc

Nicola Mining Inc

Nicola Mining Inc. is a Canada-based junior mining company. The Company maintains a 100% owned mill and tailings facility ...
View More »